Effectiveness of combining continuous cerebrospinal drainage and intermittent intrathecal urokinase injection therapy in preventing symptomatic vasospasm following aneurysmal subarachnoid haemorrhage

References

• Fisher C M, Kistler J P, Davis J M. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980; 6: 1–9
   PubMed Web of Science ®Google Scholar
• Reilly C, Amidei C, Tolentino J, Jahromi B S, Macdonald R L. Clot volume and clearance rate as independent predictors of vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg 2004; 101: 255–261
   PubMed Web of Science ®Google Scholar
• Kinouchi H, Ogasawara K, Shimizu H, Mizoi K, Yoshimoto T. Prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage by intraoperative cisternal fibrinolysis using tissue-type plasminogen activator combined with continuous cisternal drainage. Neurol Med Chir (Tokyo) 2004; 44: 569–577
   PubMed Web of Science ®Google Scholar
• Ljunggren B, Saveland H, Brandt L, Zygmunt S. Early operation and overall outcome in aneurysmal subarachnoid hemorrhage. J Neurosurg 1985; 62: 547–551
   PubMed Web of Science ®Google Scholar
• Mizukami M, Kawase T, Usami T, Tazawa T. Prevention of vasospasm by early operation with removal of subarachnoid blood. Neurosurgery 1982; 10: 301–307
   PubMed Web of Science ®Google Scholar
• Taneda M. Effect of early operation for ruptured aneurysms on prevention of delayed ischemic symptoms. J Neurosurg 1982; 57: 622–628
   PubMed Web of Science ®Google Scholar
• Usui M, Saito N, Hoya K, Todo T. Vasospasm prevention with postoperative intrathecal thrombolytic therapy: a retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone. Neurosurgery 1994; 34: 235–345
   PubMed Web of Science ®Google Scholar
• Inagawa T, Kamiya K, Matsuda Y. Effect of continuous cisternal drainage on cerebral vasospasm. Acta Neurochir (Wien) 1991; 112: 28–36
   PubMed Web of Science ®Google Scholar
• Ito U, Tomita H, Yamazaki S, Yamazaki S, Takada Y, Inaba Y. Enhanced cisternal drainage and cerebral vasospasm in early aneurysm surgery. Acta Neurochir 1986; 80: 18–23
   PubMedGoogle Scholar
• Kasuya H, Shimizu T, Kagawa M. The effect of continuous drainage of cerebrospinal fluid in patients with subarachnoid hemorrhage: a retrospective analysis of 108 patients. Neurosurgery 1991; 28: 56–59
   PubMed Web of Science ®Google Scholar
• Kawakami Y, Shimamura Y. Cisternal drainage after early operation of ruptured intracranial aneurysm. Neurosurgery 1987; 20: 8–14
   PubMed Web of Science ®Google Scholar
• Klimo P, Kestle J RW, Macdonald J D, Schmidt R H. Marked reduction of cerebral vasospasm with lumbar drainage of cerebroapinal fluid after subarachnoid hemorrhage. J Neurosurg 2004; 100: 215–224
   PubMed Web of Science ®Google Scholar
• Sakaki S, Ohta S, Kuwabara H, Shiraishi M. The role of ventricular and cisternal drainage in the early operation for ruptured intracranial aneurysms. Acta Neurochir (Wien) 1987; 88: 87–94
   PubMed Web of Science ®Google Scholar
• Kodama N, Sasaki T, Kawakami M, Sato M, Asari J. Cisternal irrigation therapy with urokinase and ascorbic acid for prevention of vasospasm after aneurysmal subarachnoid hemorrhage. Outcome in 217 patients. Surg Neurol 2000; 53: 110–118
   PubMedGoogle Scholar
• Ohman J, Servo A, Heiskanen O. Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 1991; 75: 197–201
   PubMed Web of Science ®Google Scholar
• Sasaki T, Ohta T, Kikuchi H, et al. A phase α clinical trial of recombinant human tissue-type plasminogen activator against cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 1994; 35: 597–605
   PubMed Web of Science ®Google Scholar
• Kassell N F, Helm G, Simmons N, Phillips C D, Cail W S. Treatment of cerebral vasospasm with intra-arterial papaverine. J Neurosurg 1992; 77: 848–852
   PubMed Web of Science ®Google Scholar
• Findlay J M. Current management of cerebral vasospasm. Contemp Neurosurg 1997; 19: 1–6
   Google Scholar
• Jito J, Nakasu Y, Nakasu S, Hatsuda N, Matsuda M. Tissue plasminogen activator levels after single intracisternal injection in patients with subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 2004; 44: 55–60
   PubMedGoogle Scholar
• Sasaki T, Kodama N, Kawakami M, et al. Urokinase cisternal irrigation therapy for prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2000; 31: 1256–1262
   PubMed Web of Science ®Google Scholar
• Hamada J, Kai Y, Morioka M, et al. Effect on cerebral vasospasm of coil embolization followed by microcatheter intrathecal urokinase infusion into the cisterna magna. Stroke 2003; 34: 2549–2554
   PubMed Web of Science ®Google Scholar
• Kawamoto S, Tsutsumi K, Yoshikawa G, et al. Effectiveness of the head-shaking method combined with cisternal irrigation with urokinase in preventing cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 2004; 100: 236–243
   PubMedGoogle Scholar
• Mizuno T, Hamada J, Kai Y, et al. Intrathecal urokinase infusion through a microcatheter into the cisterna magna to prevent cerebral vasospasm: experimental study in dogs. Am J Neuroradiol 2003; 24: 613–618
   PubMed Web of Science ®Google Scholar
• Moriyama E, Matsumoto Y, Meguro T, et al. Combined cisternal drainage and intrathecal urokinase injection therapy for prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 1995; 35: 732–736
   PubMedGoogle Scholar